Live Nation Entertainment (LYV) traded higher Thursday as investors digested the next procedural milestone in its antitrust battle tied to Ticketmaster. A federal judge scheduled a May 7, 2026 conference focused on how quickly the case moves into the remedies phase after a jury found Live Nation and Ticketmaster illegally maintained monopoly power earlier this month. (ticketnews.com)

After a liability verdict, the market tends to refocus on timeline and severity: when a remedies process begins, what information will be required, and whether the company can slow things down. The upcoming conference sets the stage for a fight over sequencing—whether the states can push promptly toward injunctive relief or whether proceedings are delayed while a narrower federal settlement goes through review. (ticketnews.com)

Key catalysts include the May 7 court conference and any subsequent scheduling order that clarifies dates for filings, discovery on remedies, and hearings. Investors will also watch for Live Nation’s post-trial motions and how the court handles the parallel review of the DOJ settlement framework versus the states’ push for broader relief. (ticketnews.com)